1. Search Result

Search Result

Results for "1637573-04-6" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-123875A
    Ralaniten triacetate


    Androgen Receptor Cancer
    Ralaniten triacetate (EPI-506), the pro-drug of Ralaniten, is a first-in-class, orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor. Ralaniten triacetate shows activity against both full length and resistance-related AR species, including AR-v7.